Clinical Trials · NCT01934816
Incretin and KATP Channels
- Phase
- N/A
- Recruitment status
- Terminated
- Sponsor
- Katarina Kos
- Enrollment
- 2
- Start date
- Jun 2013
- Locations
- 1 site, United Kingdom
- Primary endpoint
- Change in skin blood flow to GLP-1 and its analogues